News & Analysis as of

Applications Medicines and Healthcare Products Regulatory Agency (MHRA)

McDermott Will & Emery

Brexit and COVID-19: Changes to the Regulation of Medicines

McDermott Will & Emery on

The combination of the Coronavirus (COVID-19) pandemic and the imminent end of the Brexit transition period means a fast-changing regulatory environment for medicines. On 16 October 2020, the UK Government made changes to...more

Hogan Lovells

The MHRA issues new guidance concerning common issues in clinical trial applications

Hogan Lovells on

On 22nd March 2017, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) published a guidance (“Guidance“) identifying the most common issues that the Agency has encountered during the validation and review of...more

Hogan Lovells

UK MHRA publishes “top tips” for manufacturing authorisation applicants

Hogan Lovells on

The UK Medicines and Healthcare products Regulatory Agency (“MHRA”) has published guidance for companies submitting a Manufacturing Authorisation application or variation on common mistakes made by applicants, to help reduce...more

3 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide